TY  - JOUR
AU  - Gonzalez-Rincon, Julia
AU  - Garcia-Vela, Jose A.
AU  - Gomez, Sagrario
AU  - Fernandez-Cuevas, Belen
AU  - Nova-Gurumeta, Sara
AU  - Perez-Sanz, Nuria
AU  - Alcoceba, Miguel
AU  - Gonzalez, Marcos
AU  - Anguita, Eduardo
AU  - Lopez-Jimenez, Javier
AU  - Gonzalez-Barca, Eva
AU  - Yanez, Lucrecia
AU  - Perez-Persona, Ernesto
AU  - de la Serna, Javier
AU  - Fernandez-Zarzoso, Miguel
AU  - Deben, Guillermo
AU  - Penalver, Francisco J.
AU  - Fernandez, Maria C.
AU  - de Oteyza, Jaime Perez
AU  - Andreu, M. angeles
AU  - Ruiz-Guinaldo, M. angeles
AU  - Paz-Arias, Raquel
AU  - Garcia-Malo, M. Dolores
AU  - Recasens, Valle
AU  - Collado, Rosa
AU  - Cordoba, Raul
AU  - Navarro-Matilla, Belen
AU  - Sanchez-Beato, Margarita
AU  - Garcia-Marco, Jose A.
PY  - 2021
DO  - 10.1371/journal.pone.0257353
SN  - 1932-6203
UR  - https://hdl.handle.net/10668/25213
T2  - Plos one
AB  - Chronic Lymphocytic Leukemia (CLL) is the most prevalent leukemia in Western countries and is notable for its variable clinical course. This variability is partly reflected by the mutational status of IGHV genes. Many CLL samples have been studied in...
LA  - en
PB  - Public library science
KW  - Recurrent mutations
KW  - Clinical impact
KW  - Coding genome
KW  - Cll
KW  - Fludarabine
KW  - Notch1
KW  - Survival
KW  - Sf3b1
KW  - Tp53
KW  - Cyclophosphamide
TI  - Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM)
TY  - research article
VL  - 16
ER  -